Back
Alexandria Real Estate Equities Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
55
ARE
Alexandria Real Estate Equities
Last Price:
115.69
Seasonality Move:
4.04%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
40.96
Seasonality Move:
-0.9%
Buy
55
Alexandria Real Estate Equities (ARE)
is a Buy
Is Alexandria Real Estate Equities a Buy, Sell or Hold?
- The current Alexandria Real Estate Equities [ARE] share price is $116.39. The Score for ARE is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ARE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARE Stock Price Chart
What is Alexandria Real Estate Equities's stock price today?
-
The Alexandria Real Estate Equities share price today is $116.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.42
The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.76 | Sell |
Relative Strength Index (14 RSI): | 47.53 | Sell |
Chaikin Money Flow: | 542707 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (114.78 - 118.46) | Sell |
Bollinger Bands (100): | (116.35 - 124.47) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 52.47 | Buy |
Chaikin Money Flow: | 873891 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.82 - 42.02) | Buy |
Bollinger Bands (100): | (40.78 - 48.78) | Sell |
ARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 116.14 | Buy |
20-day SMA: | 116.17 | Buy |
50-day SMA: | 118.22 | Sell |
200-day SMA: | 115.89 | Buy |
8-day EMA: | 116.24 | Buy |
20-day EMA: | 116.69 | Sell |
50-day EMA: | 118.28 | Sell |
200-day EMA: | 119.88 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.5 | Buy |
20-day SMA: | 40.58 | Buy |
50-day SMA: | 41.51 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 40.23 | Buy |
20-day EMA: | 40.49 | Buy |
50-day EMA: | 41.77 | Sell |
200-day EMA: | 43.33 | Sell |
Alexandria Real Estate Equities Earnings Growth & ARE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.02 per share, a decrease this year of $6.40 per share, and an increase next year of $0.12 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Alexandria Real Estate Equities Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |